Shufro Rose & Co. LLC trimmed its position in shares of Avery Dennison Co. (NYSE:AVY – Free Report) by 0.3% in the 4th quarter, Holdings Channel reports. The firm owned 142,474 shares of the industrial products company’s stock after selling 448 shares during the period. Avery Dennison accounts for approximately 2.6% of Shufro Rose & […]
Avery Dennison Co. (NYSE:AVY – Get Free Report) announced a quarterly dividend on Thursday, April 25th, Wall Street Journal reports. Investors of record on Wednesday, June 5th will be paid a dividend of 0.88 per share by the industrial products company on Thursday, June 20th. This represents a $3.52 dividend on an annualized basis and […]
Investment Analysts’ price target changes for Thursday, April 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its target price boosted by Piper Sandler from $26.00 to $30.00. Piper Sandler currently has an overweight rating on the stock. Align Technology (NASDAQ:ALGN) had its target price raised by Robert W. Baird from $333.00 to $370.00. Robert W. Baird currently has […]
Investment Analysts’ price target changes for Thursday, April 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its target price boosted by JMP Securities from $14.00 to $17.00. They currently have a market outperform rating on the stock. Align Technology (NASDAQ:ALGN) had its price target raised by Morgan Stanley from $344.00 to $360.00. The firm currently has an overweight […]
Xponance Inc. lessened its stake in Avery Dennison Co. (NYSE:AVY – Free Report) by 7.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,342 shares of the industrial products company’s stock after selling 1,037 shares during the period. Xponance Inc.’s holdings in Avery […]